Hughes Financial Services
NPCE icon

Hughes Financial Services’s Neuropace NPCE Stock Holding History

Hughes Financial Services’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13 Sell
1
-8
-89% -$119 ﹤0.01% 1957
2026
Q2 		$143 Buy
9
+4
+80% +$64 ﹤0.01% 1361
2026
Q1 		$66 Sell
5
-9
-64% -$135 ﹤0.01% 1395
2025
Q4 		$216 Buy
+14
New +$187 ﹤0.01% 988

Other funds holding NPCE

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Diversified Trust
Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Hughes Financial Services's NPCE Position: Q3 2026 in Review

Hughes Financial Services reduced its Neuropace (NPCE) stake by 89% in Q3 2026, selling an estimated $119 and leaving 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

Hughes Financial Services first reported a position in NPCE in Q4 2025 and has held it in 4 quarters since. The position peaked at $216 in Q4 2025. 26 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • Hughes Financial Services held 1 share of Neuropace worth $13 as of Q3 2026.
  • Hughes Financial Services sold 8 Neuropace shares in Q3 2026, an estimated $119.
  • Neuropace made up ﹤0.01% of Hughes Financial Services's portfolio in Q3 2026, its #1957 holding.
  • Hughes Financial Services first reported a position in Neuropace in Q4 2025 and has held it in 4 quarters since.
  • Hughes Financial Services's Neuropace position peaked at $216 in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on Hughes Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.